Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin Sells Nutrition Branch for $4.6M

NEW YORK (GenomeWeb News) – Interleukin Genetics said today that it has sold its Alan James Group business to Pep Products, a subsidiary of Nutraceutical Corporation, for around $4.6 million in cash.

The Alan James Group is based in Boca Raton, Fla., and it markets nutritional supplements.

"While the Alan James Group business saw an increase in sales during the last fiscal year and we were able to introduce two new products in the last seven months, this transaction allows us to focus our efforts on growing our core genetic testing business," said Interleukin Genetics CEO, Lewis Bender.

The sale of AJG provides non-dilutive cash to continue development and promotion of our genetic testing services and products including our new brand of Inherent Health tests," Bender added.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.